Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial
- PMID: 38966936
- DOI: 10.1093/eurheartj/ehae372
Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial
Abstract
Background and aims: Drug-coated balloons (DCBs) have demonstrated favourable outcomes following endovascular therapy for femoropopliteal artery (FPA) disease. However, uncertainty remains whether the use of intravascular ultrasound (IVUS) can improve the outcomes of DCBs.
Methods: This prospective, multicentre, randomized trial, conducted at seven centres in South Korea, compared the outcomes of IVUS-guided vs. angiography-guided angioplasty for treating FPA disease with DCBs. Patients were assigned to receive IVUS-guided (n = 119) or angiography-guided (n = 118) angioplasty using DCBs. The primary endpoint was 12-month primary patency.
Results: Between May 2016 and August 2022, 237 patients were enrolled and 204 (86.0%) completed the trial (median follow-up; 363 days). The IVUS guidance group showed significantly higher primary patency [83.8% vs. 70.1%; cumulative difference 19.6% (95% confidence interval 6.8 to 32.3); P = .01] and increased freedom from clinically driven target lesion revascularization [92.4% vs. 83.0%; difference 11.6% (95% confidence interval 3.1 to 20.1); P = .02], sustained clinical improvement (89.1% vs. 76.3%, P = .01), and haemodynamic improvement (82.4% vs. 66.9%, P = .01) at 12 months compared with the angiography guidance group. The IVUS group utilized larger balloon diameters and pressures for pre-dilation, more frequent post-dilation, and higher pressures for post-dilation, resulting in a greater post-procedural minimum lumen diameter (3.90 ± 0.59 vs. 3.71 ± 0.73 mm, P = .03).
Conclusions: Intravascular ultrasound guidance significantly improved the outcomes of DCBs for FPA disease in terms of primary patency, freedom from clinically driven target lesion revascularization, and sustained clinical and haemodynamic improvement at 12 months. These benefits may be attributed to IVUS-guided optimization of the lesion before and after DCB treatment.
Keywords: Endovascular procedures; Interventional; Peripheral arterial disease; Ultrasonography.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Similar articles
-
Intravascular Ultrasound-Guided vs Angiography-Guided Drug-Coated Balloon Angioplasty in Patients With Complex Femoropopliteal Artery Disease.JACC Cardiovasc Interv. 2025 Mar 10;18(5):558-569. doi: 10.1016/j.jcin.2024.10.052. Epub 2025 Jan 22. JACC Cardiovasc Interv. 2025. PMID: 39846915 Clinical Trial.
-
Intravascular Ultrasound Predictors of 12-Month Patency Loss Following Drug-Coated Balloon Angioplasty for the Femoropopliteal Artery.Am J Cardiol. 2025 Jul 1;246:58-64. doi: 10.1016/j.amjcard.2025.03.018. Epub 2025 Mar 26. Am J Cardiol. 2025. PMID: 40154590
-
The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions: A Randomized Controlled Trial.JACC Cardiovasc Interv. 2022 Mar 14;15(5):536-546. doi: 10.1016/j.jcin.2022.01.001. JACC Cardiovasc Interv. 2022. PMID: 35272779 Clinical Trial.
-
Intravascular Ultrasound-Guided Versus Angiography-Guided Endovascular Therapy for Femoropopliteal Artery Disease: A Scoping Review.J Endovasc Ther. 2025 Jun;32(3):627-634. doi: 10.1177/15266028231197396. Epub 2023 Sep 9. J Endovasc Ther. 2025. PMID: 37688486
-
Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.J Vasc Surg. 2019 Sep;70(3):981-995.e10. doi: 10.1016/j.jvs.2019.01.080. Epub 2019 May 21. J Vasc Surg. 2019. PMID: 31126769
Cited by
-
In-Hospital Outcomes and Temporal Trends of Surgical Versus Intravascular Ultrasound-Guided Endovascular Interventions for Femoropopliteal Disease.J Soc Cardiovasc Angiogr Interv. 2025 Mar 25;4(6):102617. doi: 10.1016/j.jscai.2025.102617. eCollection 2025 Jun. J Soc Cardiovasc Angiogr Interv. 2025. PMID: 40630255 Free PMC article.
-
A Systematic Review on the Use of Intravascular Ultrasound and Optical Coherence Tomography During Femoropopliteal Endovascular Intervention.Catheter Cardiovasc Interv. 2025 Aug;106(2):949-961. doi: 10.1002/ccd.31636. Epub 2025 May 29. Catheter Cardiovasc Interv. 2025. PMID: 40437982 Free PMC article. Review.
-
Predictors of Patency Following Infrainguinal Arterial Interventions Under Intravascular Ultrasound Guidance: Analysis from the iDissection Studies.Vasc Health Risk Manag. 2025 Jun 30;21:505-518. doi: 10.2147/VHRM.S518392. eCollection 2025. Vasc Health Risk Manag. 2025. PMID: 40621070 Free PMC article.
-
Clinical outcome of low-dose and high-dose drug-coated balloon angioplasty with intraplaque wiring for femoropopliteal chronic total occlusion lesions.Cardiovasc Interv Ther. 2025 Apr;40(2):337-343. doi: 10.1007/s12928-024-01067-5. Epub 2024 Dec 3. Cardiovasc Interv Ther. 2025. PMID: 39623253
-
The Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infrapopliteal Endovascular Intervention.J Soc Cardiovasc Angiogr Interv. 2025 Mar 18;4(3Part A):102509. doi: 10.1016/j.jscai.2024.102509. eCollection 2025 Mar. J Soc Cardiovasc Angiogr Interv. 2025. PMID: 40231048 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical